Effectiveness and Bioinformatics Analysis of Yiqi and Blood-Activating Therapy Combined with Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

<b>Objective:</b> To systematically evaluate the efficacy and explore the mechanisms of Yiqi and blood-activating traditional Chinese medicine (TCM) combined with chemotherapy in treating non-small cell lung cancer (NSCLC). <b>Methods:</b> Randomized controlled trials (RCTs) on chemotherapy combined...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Lu Xu, Weiling Lv, Ye Cheng, Chunjia Ping, Yizheng Wang, He Wang, Fan Lin
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2025-09-01
Ráidu:	Pharmaceuticals
Fáttát:	Yiqi and blood-activating therapy non-small cell lung cancer (NSCLC) meta-analysis data mining network pharmacology tumor immune microenvironment
Liŋkkat:	https://www.mdpi.com/1424-8247/18/10/1442
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!